search

Grégory Nain, DataThings, speaks about finding investors in Luxembourg“DataThings is a software engineering company specialised in the development of machine learning, data analytics, digital twins and artificial intelligence solutions for all industrial sectors,” explains Grégory Nain. “We help clients uncover the potential of their data by co-designing made-to-measure data processing engines and creating web applications to pilot them and display their results intuitively. Luxembourg is our main market, but we are currently expanding to France.”

Corporate investors

A spin-off from the University of Luxembourg incorporated in 2017, DataThings has managed to find investors in Luxembourg. “We had our first fundraising round in late 2020, aimed at boosting the development of several products in order to complement our existing services,” says Mr Nain. “We chose two industrial investors established in Luxembourg: sustainable energy player Encevo and international engineering company Paul Wurth. They are now both clients and partners with whom we continue to develop products for the smart electricity grid and for facilitating the use of machine learning in industry. In addition to financing, they provide us with in-depth knowledge of their respective markets and access to their business networks to help us grow.”

Our investors are now both clients and partners with whom we continue to develop products for the smart electricity grid and for facilitating the use of machine learning in industry.

The next step for the company is now to promote its products further on the market. “We will expand our service portfolio with new offers of consultancy and training on how to leverage machine learning to develop efficient and production-ready artificial intelligence solutions that are tailor-made for each business.”

Photo: © Luxinnovation / Luc Deflorenne

Read more

Rendering data actionable to drive healthcare innovation: ITTM

06-12-2023

Health data is proving to be a formidable catalyst for change. However, the mere accumulation of data does not guarantee transformative outcomes. The essence lies in making data actionable – a challenge that Luxembourg medical data specialist ITTM has taken up.
Read more

Entering the European market with ease

29-11-2023

In recent years, Luxembourg has emerged as a dynamic hub for innovation, boasting a robust ecosystem that encompasses a multitude of incubators, accelerators, specialised agencies, investors, and innovation hubs. This thriving ecosystem has played a pivotal role in nurturing and propelling numerous successful enterprises across diverse industries onto the global stage. Top executives leading some of Luxembourg’s key structures explain what the ecosystem offers and why this might just be the smartest and most cost-effective way for a soft-landing and to gain a foothold in foreign markets.
Read more

Pioneering “gamified neuroscience” for brain disorders

27-11-2023

Luxembourg-based company Myelin-H is developing a revolutionary software technology for the remote monitoring and management of neurological disorders. The company’s CEO, Zied Tayeb, sheds light on the company’s mission to make a difference and how a personal story sparked the conception of his startup.
Read more

Accessing the European healthtech market

22-11-2023

Healthtech solutions are subject to rather complex regulatory requirements guaranteeing health standards and protection in the EU. Luxembourg’s national innovation agency Luxinnovation manages a range of initiatives aimed at supporting healthtech companies from strategy development to European market access.
Read more

On the road to personalised medicine

20-11-2023

In 2008, the Luxembourg government launched its Sciences and Health Technologies Action Plan to diversify its economy, nurture health technology innovation and stimulate the shift towards personalised medicine. Fifteen years later, the country is home to internationally renowned biomedical research centres and a growing community of healthtech companies focusing, in particular, on digital health, digital medical devices and in vitro diagnostics.
Read more

Resources all news

Fermer